/People

Doug Cole

Investor

Managing Partner at Flagship Pioneering · Board director at Torque Therapeutics

Cambridge, Massachusetts

Writes $500K – $15M checks · typically $1.5M

Find your path to Doug

427 people in our graph can introduce you to Doug.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Elias Zerhouni to introduce you to Doug

You →Elias · together at Johns Hopkins Hospital (1986–1987) →Doug

Ask Jamie Chen to introduce you to Doug

You →Jamie · together at Johns Hopkins Hospital →Doug

Ask Sam Okafor to introduce you to Doug

You →Sam · 10 people · together at Flagship Pioneering →Doug

Sign up to find every way you can get introduced to Doug

  • Your email: the people you already email who know Doug
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Doug
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Douglas Cole, a former clinician-turned-investor, has spent over two decades conceiving and chairing platform biotech companies (Sigilon, Repertoire, Foghorn) focused on chromatin regulation, immune repertoire mapping and encapsulated cell therapies.

Contact· self-published, not guessed

Invests in

AgTechAI & Machine LearningBiotechClimate TechFoodTechHealthtech

Board director at Torque Therapeutics

Intro paths

→

In turn, Doug can intro founders to Torque Therapeutics's investors below.

Co-founders at Torque Therapeutics

UB
Ulrik B. NielsenMr. Nielsen is the President of the Issuer.

Experience

  1. Flagship PioneeringManaging Partnercurrent2001 — present
  2. Vertex PharmaceuticalsProgram Executive1997 — 2001
  3. Cytotherapeutics, Inc.Medical Director1996 — 1997
  4. Massachusetts General HospitalAssistant in Neurology1992 — 1996
  5. Massachusetts General HospitalFellow in Neurology1990 — 1992
  6. Massachusetts General HospitalResident in Neurology1987 — 1990
  7. Harvard Medical SchoolInstructor in Neurology1992 — 1996
  8. Johns Hopkins HospitalIntern in Internal Medicine, Osler Medical Service1986 — 1987

Skills & more

Start-up Ventures4Venture Capital20Entrepreneurship5Biotechnology16Drug Discovery1Drug Development5Lifesciences5Medical Devices6Medicine2Medical Diagnostics1

From Doug's professional profile.

Investments

Per curated public sources.

Colleagues at Flagship Pioneering

Network1

Investors connected to Doug in public investor directories — a warm-intro map.

Frequently asked questions

Who is Doug Cole?
Douglas Cole, a former clinician-turned-investor, has spent over two decades conceiving and chairing platform biotech companies (Sigilon, Repertoire, Foghorn) focused on chromatin regulation, immune repertoire mapping and encapsulated cell therapies.
Where does Doug Cole work?
Doug Cole is Managing Partner at Flagship Pioneering and Board director at Torque Therapeutics.
What does Doug Cole invest in?
Doug Cole invests in AgTech, AI & Machine Learning, Biotech, Climate Tech, FoodTech, Healthtech.
What check size does Doug Cole write?
Doug Cole typically writes checks of $500K – $15M.
What companies has Doug Cole invested in?
Investments tracked here include Agios Pharmaceuticals, Avedro, AVEO Oncology, Concert Pharmaceuticals, Denali Therapeutics, Editas Medicine, Empress Therapeutics, Foghorn Therapeutics, Harbinger Health, Moderna, Quanterix, Repertoire Immune Medicines, and 6 more.
Where did Doug Cole go to school?
Doug Cole studied at Dartmouth College (AB, English); University of Pennsylvania School of Medicine (Doctor of Medicine (M.D.)).

Same school

Shared employers